Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Geron Q2 2024 GAAP EPS $(0.10), Inline, Sales $780.000K Beat $274.857K Estimate

Author: Benzinga Newsdesk | August 08, 2024 07:17am
Geron (NASDAQ:GERN) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. The company reported quarterly sales of $780.000 thousand which beat the analyst consensus estimate of $274.857 thousand by 183.78 percent. This is a 2.59K percent increase over sales of $29.000 thousand the same period last year.

Posted In: GERN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist